Kythera Biopharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 23   

Articles published

KYTH 34.90 -0.34 (-0.96%)
price chart
KYTHERA Biopharmaceuticals Submits New Drug Submission to Health ...
WESTLAKE VILLAGE, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it submitted a New Drug Submission (NDS) to Health Canada seeking approval for the company's investigational drug, ...
Related articles »  
KYTHERA Biopharmaceuticals to Release Second Quarter 2014 Operating ...
WESTLAKE VILLAGE, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its second quarter 2014 operating results and will host an investor call and webcast at 4:30 p.m.
Related articles »  
Hot Stocks: Mediabistro Inc. (NASDAQ:MBIS), NCR Corp. (NYSE:NCR), Kythera ...
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) on 7 August announced GAAP Net loss was $19.5 million for the second quarter of 2014, compared to $12.3 million for the second quarter of 2013.
Don't Miss: Ignyta (NASDAQ:RXDX), Kythera Biopharmaceuticals (NASDAQ ...
Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) announced it submitted a New Drug Submission (NDS) to Health Canada seeking approval for the company's investigational drug, ATX-101 (deoxycholic acid), as an injectable treatment for the reduction of ...
Insider Selling: KYTHERA Biopharmaceuticals CEO Unloads 1828 Shares of ...
KYTHERA Biopharmaceuticals logo KYTHERA Biopharmaceuticals (NASDAQ:KYTH) CEO Keith R. Leonard unloaded 1,828 shares of KYTHERA Biopharmaceuticals stock on the open market in a transaction that occurred on Monday, August 4th. The shares ...
Morning Buzz: GW Pharmaceuticals (NASDAQ:GWPH), Kythera ...
On 7 AUG Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) reported financial results for its second quarter 2014 and provided an update on recent accomplishments.
Hot Stock List : Infoblox Inc. (NYSE:BLOX), Google (NASDAQ:GOOG), Sapient ...  WallStreet Scope
Related articles »  
Insider Selling: KYTHERA Biopharmaceuticals Director Sells 1505 Shares of ...
The company reported ($3.18) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.67) by $2.51. Analysts expect that KYTHERA Biopharmaceuticals will post $-3.33 EPS for the current fiscal year.
Related articles »  
KYTHERA Biopharmaceuticals CEO Keith R. Leonard Sells 1828 Shares (KYTH)
The company reported ($3.18) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.67) by $2.51. Analysts expect that KYTHERA Biopharmaceuticals will post $-3.33 EPS for the current fiscal year.
KYTHERA Biopharmaceuticals CEO Sells $64163 in Stock (KYTH)  Watch List News (press release)
Related articles »  
Investors Are Watching : Verizon Communications (NYSE:VZ), Ultra Clean ...
KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its second quarter 2014 and provided an update on recent accomplishments.
KYTHERA Biopharmaceuticals Releases Second Quarter 2014 Operating Results
WESTLAKE VILLAGE, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc.(Nasdaq:KYTH) today reported financial results for its second quarter 2014 and provided an update on recent accomplishments.
Related articles »